Hepatocellular Carcinoma (HCC) is one of the most common types of primary liver cancer.
Current treatment options have limited efficacy against this malignancy, primarily owing to …

Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths
worldwide with the incidence of recurrence being as high as 88% even among patients who …

Cancer cells voraciously consume nutrients to support their growth, exposing metabolic
vulnerabilities that can be therapeutically exploited. Here, we show in hepatocellular …

The systemic drug has historically been preferred for the treatment of the majority of
pathological conditions, particularly liver cancer. Indeed, this mode of treatment is …

Hepatocellular carcinoma is a highly aggressive and difficult-to-treat type of cancer.
Incorporating urea functionality into the backbone of organoselenium compounds is …

Melatonin (N-acetyl-5-methoxytryptamine) is an indoleamine with antioxidant, chronobiotic
and anti-inflammatory properties; reduced levels of this hormone are associated with higher …

Background Liver cancer (LC) is considered as one of the most dominant malignant tumors
which ranked 4th and 6th in terms of global mortality and incidence, respectively. This work …

Primary liver cancer (PLC) is a heterogeneous group of disorders arising with the
background of chronic liver disease (CLD) owing to varying etiologies. PLC carries a high …

Liver cancer remains among the leading causes of cancer-related deaths worldwide. This is
due to many reasons, including limitations of available drugs, late diagnosis due to the …

Objective Childhood cancers are a significant cause of child deaths worldwide. This study
examines the burden of 33 childhood cancers in 183 countries. Methods The estimates of …